Seacoast Banking Corporation of Florida heads into its Q1 2026 print with a notable surge in short positioning — the sharpest divergence from its own recent history in months.
Short sellers have added aggressively in April. SI as a percentage of the free float hit 5.27%, up more than a third from a month ago, with the bulk of the build arriving after April 10. That jump — from roughly 3.8 million to 5.1 million shares short in under three weeks — is the standout feature of this setup. Despite the elevated SI reading, the borrow market remains loosely priced at 0.51% cost to borrow, and borrow availability is wide, with shares readily lent. This tells a story of deliberate positioning rather than a supply-constrained squeeze environment. The ORTEX short score edged to 47.1, a recent high for the name, while days to cover run at 4.5 on FINRA official data.
Options positioning offers a contrasting angle. Call interest dominates heavily — the put/call ratio is running at 0.064, slightly below its already low 20-day average of 0.067, and more than 1.5 standard deviations below that mean. At the 52-week low of 0.044 for context, PCR has never really moved into defensive territory for this name, and there is no sign of hedging activity ahead of the print. The stock itself is $31.73, up 8% over the past month but off about 1.6% on the week — roughly in line with a broader pullback across regional bank peers, most of which lost 1-5% over the same period.
The bull case centres on margin recovery. Core net interest margin has been expanding, and ROA projections for 2026 have risen to around 1.30% — a meaningful step up from prior estimates of 1.10%. The bears focus on deposit contraction, which fell 2% quarter-over-quarter in the prior print, and integration risks tied to recent acquisitions. Keefe Bruyette & Woods has steadily raised its target through each earnings cycle since mid-2025, arriving at $38 with an Outperform rating as of February 2026 — the most recent analyst action on record. The consensus mean target of $35.42 implies roughly 12% upside from current levels, though this consensus data is approximately four weeks old.
On the ownership side, BlackRock added 1.3 million shares in the most recent quarter and now holds nearly 14% of the company. Vanguard added 700,000 shares. That sustained institutional buying provides a structural floor, even as short sellers have built their position into this report. Insider activity, by contrast, ran the other way — the CEO, CFO, and several other executives all sold small parcels on April 1, though at low significance scores and modest aggregate values.
The print will test whether NIM expansion is sustainable enough to justify a valuation re-rating, or whether deposit pressure and integration costs draw more shorts to a stock that has already attracted the heaviest short build of the year.
See the live data behind this article on ORTEX.
Open SBCF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
